Bausch Health Companies BHC
NYSE BHC
$6.16 -0.26 (-4.12%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Asset Writedowns and Impairment (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Asset Writedowns and Impairment came in at $9.0 million in Q2 2026, up 28.57% quarter-over-quarter from $7.0 million in Q4 2025.

Analysis

Bausch Health Companies (BHC) Asset Writedowns and Impairment (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Asset Writedowns and Impairment across 13 years of filings, most recently posting $9.0 million for Q2 2026.

  • In Q2 2026, Asset Writedowns and Impairment changed N/A year-over-year to $9.0 million; the TTM figure through Jun 2026 stood at $17.0 million (down 26.09% YoY), while the FY2025 annual figure was $8.0 million, down 72.41% from the prior year.
  • Asset Writedowns and Impairment came in at $9.0 million for Q2 2026 at Bausch Health Companies, up from $7.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $37.0 million in Q2 2023 to a low of $1.0 million in Q3 2022.
  • Average Asset Writedowns and Impairment over 5 years is $9.6 million, with a median of $6.5 million recorded in 2022.
  • Year-over-year, Asset Writedowns and Impairment plunged 94.59% in 2022 and soared 516.67% in 2023.
  • Over 5 years, Asset Writedowns and Impairment stood at $1.0 million in 2022, then surged by 300.0% to $4.0 million in 2023, then jumped by 475.0% to $23.0 million in 2024, then sank by 69.57% to $7.0 million in 2025, then increased by 28.57% to $9.0 million in 2026.
  • Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $9.0 million in Q2 2026, $7.0 million in Q4 2025, and $1.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.00 Mn
Dec 31, 2025 7.00 Mn
Sep 30, 2025 1.00 Mn
Dec 31, 2024 23.00 Mn
Jun 30, 2024 5.00 Mn
Mar 31, 2024 1.00 Mn
Sep 30, 2023 4.00 Mn
Jun 30, 2023 37.00 Mn
Mar 31, 2023 13.00 Mn
Sep 30, 2022 1.00 Mn
Jun 30, 2022 6.00 Mn
Mar 31, 2022 8.00 Mn
Dec 31, 2021 21.00 Mn
Sep 30, 2021 18.00 Mn
Jun 30, 2021 47.00 Mn
Mar 31, 2021 148.00 Mn
Dec 31, 2020 97.00 Mn
Sep 30, 2020 2.00 Mn
Jun 30, 2020 1.00 Mn
Mar 31, 2020 14.00 Mn